This combined solution synergizes to overcome adaptive immune resistance induced by intra-tumoral PD-1 expressing CD8+ T cells, leading to an effective IFNγ-mediated antitumor immune response and a long-term cure of glioma-bearing mice [72]. This evidence concerns the gene CD8A and central nervous system cancer.